KATHRYN STENSGARD: Open Payments
NPI 1437591062 · BISMARCK, ND. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,126 in 73 payments from 16 companies in 2025. Trend: 2023 $1,303 · 2024 $1,275 · 2025 $1,126
Food & beverage: $1,126
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 13 | $175 |
| Novo Nordisk Inc | 11 | $173 |
| ABBVIE INC. | 12 | $169 |
| Amgen Inc. | 10 | $145 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $86 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $71 |
| PFIZER INC. | 4 | $61 |
| E.R. Squibb & Sons, L.L.C. | 3 | $60 |
| Phathom Pharmaceuticals, Inc. | 3 | $39 |
| Madrigal Pharmaceuticals | 1 | $34 |
Products named: MOUNJARO, JARDIANCE, Ozempic, VRAYLAR, EVENITY, Kerendia, QULIPTA, OTEZLA.
Industry payments across ND — which companies pay providers there.
